Angiotensin-converting enzyme 2 (ACE2) – the receptor used by the SARS-CoV-2 virus as a gateway to enter and infect host cells – has garnered significant attention for the wrong reasons over recent months. But could it also point towards an exit route out of this pandemic? In an interview with Technology Networks, the renowned immunologist […]

In this episode features to David Schull, President of Russo Partners. Here, he discusses his strategies for gaining traction with clients, how he balances building relationships without being pushy, and more.

The key to Athira Pharma’s approach to Alzheimer’s disease is already inside each of us: a repair mechanism that can regenerate damaged neurons. What’s needed to begin the process is a pharmacological kickstart. Athira (NASDAQ: ATHA) is developing a drug intended to turn on the repair pathway. The company’s experimental therapy is a small molecule […]